(Q73597612)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12836707%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Immune modulation of cardiac function: a new frontier (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12836707%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Sasayama S

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12836707%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 December 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12836707%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cardiac Failure

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12836707%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12836707%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12836707%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

331-335

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12836707%20AND%20SRC:MED&resulttype=core&format=json

T-lymphocyte interactions in cardiac transplant rejection

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Myocyte injury and contraction abnormalities produced by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Immune cytokines and cardiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Mechanisms of immune-mediated myocyte injury

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

A new method for assessment of cultured cardiac myocyte contractility detects immune factor-mediated inhibition of beta-adrenergic responses

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Increased circulating cytokines in patients with myocarditis and cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

cis-acting sequences required for class II gene regulation by interferon gamma and tumor necrosis factor alpha in a murine macrophage cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Serum interleukin 6 levels become elevated in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Cytokines in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Hypoxic stress induces cardiac myocyte-derived interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Cytokine signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Vesnarinone: a new inotropic agent for treating congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Inhibition of cytokine production by a new inotropic agent, vesnarinone, in human lymphocytes, T cell line, and monocytic cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980001-6

7 January 2021

10.1016/S1071-9164(05)80001-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12836707%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference